HOME >> BIOLOGY >> NEWS
Magnetic field exposure associated with childhood leukemia

Researchers at the University of Toronto and the Hospital for Sick Children have found an association between magnetic field exposures in residences and the risk of developing childhood leukemia.

The study, reported in two separate papers in the current issues of the International Journal of Cancer (IJC) and the journal Cancer Causes and Control (CCC), shows that children with higher exposures to magnetic fields in residences are two to four times more likely to develop leukemia compared to children who are less exposed. The study comprehensively measured magnetic field exposures inside and outside the children's homes. Wire code was also assigned to each residence. For some children, EMF exposures were measured by a personal monitor.

The authors report in IJC that overall, wire code -- a surrogate indicator of magnetic field exposure based on the physical characteristics of the line and proximity of the residence to power lines -- was not associated with an increased risk of developing leukemia. However, leukemia risk was elevated for children diagnosed at less than six years of age in relation to magnetic field exposures in residences occupied during the first two years of life.

A subset of the total study population wore a personal monitoring device which measured EMF during usual activities in the home over 48 hours. As reported in CCC, exposure to magnetic fields was associated with a two-fold increase in risk of developing leukemia.

When other factors such as residential mobility, power consumption, child's medical history and other environmental exposures were taken into account, children exposed to higher levels of magnetic fields were 4.5 times more likely to develop leukemia compared to less exposed children. Risks were higher for children diagnosed at less than six years of age and for those with acute lymphoblastic leukemia -- the most common type of leukemia in children.

"As t
'"/>

Contact: Steven de Sousa
steven.desousa@utoronto.ca
416-978-5949
University of Toronto
16-Jun-1999


Page: 1 2

Related biology news :

1. Magnetic tag lets scientists track stem cells in living rat
2. Magnetic fluids offer hope for treatment of retinal detachment
3. Magnetic fields may hold key to malaria treatment, UW researchers find
4. Magnetic resonance imaging of sexual intercourse is both possible and useful...
5. Magnetic Fluids More Complex Than Previously Thought
6. Report On Electrical And Magnetic Fields Released; Public Invited To Comment At Regional Meetings
7. Scientists Use Magnetic Field As Alternative To Space-Based Zero Gravity
8. Moving DNA Molecules With Magnetic Tweezers
9. Newly Discovered Bacteria Produce Magnetic Material
10. Health of worlds sea lions the focus of Wakefield Symposium
11. From orchards and fields to townhouses and offices

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Magnetic field exposure associated with childhood leukemia

(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
(Date:3/12/2015)... , March 12, 2015 The mascots of ... Children,s Hospital, part of Wake Forest Baptist Medical Center. ... for the 2015 ACC Men,s Basketball Tournament. Young patients ... them and getting their autographs. Brenner Children,s ... It is the only children,s hospital in northwest ...
(Date:3/10/2015)... 2015  Continuing its 167-year history of offering the ... The Eye Scanning Password Authenticator , a device ... secure websites or sensitive data. Employing the ... borders, the device has a small camera that scans ... iris, converting them into an encrypted ID that cannot ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
(Date:3/25/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... of recent discussions with certain shareholders representing approximately 45% ... after dealing with certain matters including the appointment of ... on March 26, 2015 (the "Meeting") it intends to ... will take place when the Meeting reconvenes. The Meeting ...
(Date:3/25/2015)... 25, 2015  S&P Capital IQ (MHFI) announced ... Report coverage on Abattis Bioceuticals Corp . ... is a specialty biotechnology company with capabilities through ... marketing proprietary ingredients, bio-similar compounds, patented equipment and ... North America . The company seeks to ...
(Date:3/25/2015)... , CAMBRIDGE, Mass. and ... NextCODE, which provides comprehensive capabilities for using the genome to ... on their publication of the largest studies of whole-genome data ... online in Nature Genetics – are ... sequence variation, authored by a team of deCODE scientists led ...
(Date:3/25/2015)... CA (PRWEB) March 25, 2015 ... for Novel Mechanism of Action in Neuromuscular Diseases ... 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced the ... skeletal muscle troponin activator tirasemtiv in the journal ... Phase IIa “Evidence of Effect” or hypothesis-generating clinical ...
Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
Cached News: